NewGene Plans to Offer 454-Based Genetic Testing for UK's NHS, Other Clients by Early 2010
August 04, 2009
NewGene Plans to Offer 454-Based Genetic Testing for UK's NHS, Other Clients by Early 2010
The company expects to use Roche's 454 technology to offer full-gene sequencing tests at a lower cost and faster turnaround time than existing providers using Sanger sequencing.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Austrian Blood Service Approved for Clinical HLA Typing Using 454 Sequencing
March 6, 2013 / Clinical Sequencing News - Genoptix Offers Targeted Sequencing on Ion PGM to Guide Treatment Decisions for Metastatic Melanoma
March 28, 2012 / Clinical Sequencing News - Montreal Heart Institute Developing GnuBio Sequencing Panel for Sudden Cardiac Death Test
February 1, 2012 / Pharmacogenomics Reporter - Baylor to Evaluate Exome Sequencing of Childhood Brain and Solid Tumors under NHGRI Grant
February 1, 2012 / Clinical Sequencing News - Sequencing/Genotyping Combination Yields Somatic Mutations with Prognostic and Dx Potential in MDS
July 27, 2011 / Clinical Sequencing News